Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
A huge proportion of medical research is funded by industry even though studies show company-sponsored studies tend to overstate benefits, playdown harms.
For almost 20 years, malfunctions and injuries linked to 108 medical devices were funneled into an FDA database that few knew existed.
Hype has led some to pay thousands of dollars for stem cell treatments that promise to cure ailments but that often don’t help and may harm patients.
Using instructions freely available online, do-it-yourselfers ― who belong to what’s known as the “open-source community” ― close the loop between an insulin pump and a continuous glucose monitor.
In 2004, Californians voted to shell out billions in taxpayer money to fund stem cell research. But 15 years later, some are asking ‘Where are the cures?”
Physicians profit handsomely from infusions. And they are paid based on the prescribed drug’s average price giving them an incentive to pick the most expensive.
Amazon thinks Alexa, its virtual assistant, could help diagnose mental illness, autism, concussions and even tell when you’re having a heart attack.
Scientists have created the first completely artificial protein switch that can work inside living cells to modify—or even commandeer—the cell’s complex internal circuitry. The switch is dubbed “LOCKR,” short for Latching, Orthogonal Cage/Key pRotein. Companion papers published July 24 in…
The benefits of stem cells are hotly debated in the medical community, and federal regulators have warned the public to beware of clinics that peddle unapproved injections as a cure-all.
UW researchers have developed software that would allow smart speakers and smartphones to detect heart attacks in the home and call for help.
ECMO is designed to be a bridge to somewhere — recovery, transplantation or an implanted heart device. But for some patients it can be “bridge to nowhere.”
My doctor’s nurse is far better equipped to answer a question about my ongoing health problem than someone at a call center reading from a script.
Shortly after the device’s recall, the FDA and Medtronic made a deal to keep reports of its malfunction — now totaling 50,000 — shielded from public scrutiny.
There are more than 700 clinics in the U.S. selling unproven stem cell cellular therapies, generating $2 billion in global business that is largely unregulated.